INVIVO THERAPEUTICS HOLDINGS CORP. Quarterly Nonoperating Income (Expense) in USD from Q2 2010 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Invivo Therapeutics Holdings Corp. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2010 to Q3 2023.
  • Invivo Therapeutics Holdings Corp. Nonoperating Income (Expense) for the quarter ending September 30, 2023 was $131K, a 191% increase year-over-year.
  • Invivo Therapeutics Holdings Corp. Nonoperating Income (Expense) for the twelve months ending September 30, 2023 was $529K, a 690% increase year-over-year.
  • Invivo Therapeutics Holdings Corp. annual Nonoperating Income (Expense) for 2022 was $160K, a 3100% increase from 2021.
  • Invivo Therapeutics Holdings Corp. annual Nonoperating Income (Expense) for 2021 was $5K, a 78.3% decline from 2020.
  • Invivo Therapeutics Holdings Corp. annual Nonoperating Income (Expense) for 2020 was $23K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $529K $131K +$86K +191% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $443K $148K +$137K +1245% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $306K $156K +$146K +1460% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-12
Q4 2022 $160K $94K +$93K +9300% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-01
Q3 2022 $67K $45K +$43K +2150% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $24K $11K +$10K +1000% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $14K $10K +$9K +900% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 $5K $1K +$2K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-01
Q3 2021 $3K $2K -$2K -50% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 $5K $1K -$5K -83.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $10K $1K -$13K -92.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $23K -$1K +$632K +99.8% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-07
Q3 2020 -$609K $4K -$49K -92.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$560K $6K -$98K -94.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 -$462K $14K -$129K -90.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 -$333K -$633K -$1.12M -231% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-01
Q3 2019 $785K $53K +$1.12M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 -$330K $104K +$10.2M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11
Q1 2019 -$10.6M $143K +$95K +198% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 -$10.7M $485K +$467K +2594% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-20
Q3 2018 -$11.1M -$1.06M +$1.97M +65% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 -$13.1M -$10.1M -$10.7M -1828% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 -$2.38M $48K -$230K -82.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 -$2.15M $18K Oct 1, 2017 Dec 31, 2017 10-K 2019-04-01
Q3 2017 -$3.03M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $586K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $278K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-07
Q1 2012 -$20.6M $5.61M +$5.49M +4474% Jan 1, 2012 Mar 31, 2012 10-Q 2012-05-14
Q4 2011 -$26.1M -$32.6M Oct 1, 2011 Dec 31, 2011 10-K 2012-03-15
Q3 2011 $5.28M +$5.37M Jul 1, 2011 Sep 30, 2011 10-Q 2011-11-14
Q2 2011 $1.16M +$1.33M Apr 1, 2011 Jun 30, 2011 10-Q 2011-08-10
Q1 2011 $123K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-14
Q3 2010 -$88.1K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 -$176K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.